Sunday, 25 March 2007


The March issue of Anesthesia and Analgesia has a review article about the new muscle relaxant antagonist, Sugammadex. Its advantages are direct inhibition of the relaxant and no autonomic or cardiovascular side effects. It is also effective after only recent administration of relaxant and so can be used in situations as an alternative to suxamethonium. It is most effect after rocuronium and vecuronium, but not other relaxantants.

1 comment:

  1. So this drug wouldn't be a possible treatment for a pseudocholinesterase deficiency reaction? What I mean is does it have any effect after succinylcholine administration?